Cargando…
Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556659/ https://www.ncbi.nlm.nih.gov/pubmed/33054096 http://dx.doi.org/10.3324/haematol.2019.238808 |
| _version_ | 1783594267358265344 |
|---|---|
| author | Ghia, Paolo Coutre, Steven E. Cheson, Bruce D. Barrientos, Jacqueline C. Hillmen, Peter Pettitt, Andrew R. Zelenetz, Andrew D. Shreay, Sanatan Hallek, Michael Furman, Richard R. |
| author_facet | Ghia, Paolo Coutre, Steven E. Cheson, Bruce D. Barrientos, Jacqueline C. Hillmen, Peter Pettitt, Andrew R. Zelenetz, Andrew D. Shreay, Sanatan Hallek, Michael Furman, Richard R. |
| author_sort | Ghia, Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7556659 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75566592020-10-15 Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial Ghia, Paolo Coutre, Steven E. Cheson, Bruce D. Barrientos, Jacqueline C. Hillmen, Peter Pettitt, Andrew R. Zelenetz, Andrew D. Shreay, Sanatan Hallek, Michael Furman, Richard R. Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-02-13 /pmc/articles/PMC7556659/ /pubmed/33054096 http://dx.doi.org/10.3324/haematol.2019.238808 Text en Copyright© 2020 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Ghia, Paolo Coutre, Steven E. Cheson, Bruce D. Barrientos, Jacqueline C. Hillmen, Peter Pettitt, Andrew R. Zelenetz, Andrew D. Shreay, Sanatan Hallek, Michael Furman, Richard R. Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial |
| title | Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial |
| title_full | Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial |
| title_fullStr | Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial |
| title_full_unstemmed | Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial |
| title_short | Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial |
| title_sort | impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase iii randomized trial |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556659/ https://www.ncbi.nlm.nih.gov/pubmed/33054096 http://dx.doi.org/10.3324/haematol.2019.238808 |
| work_keys_str_mv | AT ghiapaolo impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT coutrestevene impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT chesonbruced impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT barrientosjacquelinec impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT hillmenpeter impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT pettittandrewr impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT zelenetzandrewd impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT shreaysanatan impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT hallekmichael impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial AT furmanrichardr impactofidelalisibonhealthrelatedqualityoflifeinpatientswithrelapsedchroniclymphocyticleukemiainaphaseiiirandomizedtrial |